CCL3L1 copy number and susceptibility to malaria

Infection, Genetics and Evolution

Volumn 12, Issue 5, 2012, Pages 1147-1154

  Carpenter, Danielle ^a   Färnert, Anna ^b   Rooth, Ingegerd ^c   Armour, John A L ^a   Shaw, Marie Anne ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

CCL3L1; Haplotype; Malaria; MIP 1

Indexed keywords

HEMOGLOBIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CCL3L1 GENE; CHILD; CONTROLLED STUDY; COPY NUMBER VARIATION; DIPLOIDY; DISEASE CONTROL; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ETHNIC GROUP; FAMILY STUDY; FEMALE; GENE; GENE DOSAGE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALARIA; MALE; PARASITE LOAD; PHENOTYPE; PILOT STUDY; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TANZANIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEMOGLOBINS; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITE LOAD; PLASMODIUM FALCIPARUM; TANZANIA;

EID: 84860367466     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.021     Document Type: Article

References (42)

1. Abecasis G.R., Cardon L.R., Cookson W.O.C. A general test of association for quantitative traits in nuclear families. The American Journal of Human Genetics 2000, 66:279-292.
2. Abrams E.T., Brown H., Chensue S.W., Turner G.D.H., Tadesse E., Lema V.M., Molyneux M.E., Rochford R., Meshnick S.R., Rogerson S.J. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. The Journal of Immunology 2003, 170:2759-2764.
3. Altmüller J., Palmer L.J., Fischer G., Scherb H., Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. American Journal of Human Genetics 2001, 69:936-950.
4. Anyona S.B., Kempaiah P., Raballah E., Ouma C., Were T., Davenport G.C., Konah S.N., Vulule J.M., Hittner J.B., Gichuki C.W., Ong'echa J.M., Perkins D.J. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality. Infection and Immunity 2011, 79:4923-4932.
5. Awandare G.A., Martinson J.J., Were T., Ouma C., Davenport G.C., Ong'echa J.M., Wang W., Leng L., Ferrell R.E., Bucala R., Perkins D.J. MIF (Macrophage Migration Inhibitory Factor) promoter polymorphisms and susceptibility to severe malarial anemia. Journal of Infectious Diseases 2009, 200:629-637.
6. Belnoue E., Kayibanda M., Deschemin J.-C., Viguier M., Mack M., Kuziel W.A., Renia L. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 2003, 101:4253-4259.
7. Belnoue E., Potter S.M., Rosa D.S., Mauduit M., Grüner A.C., Kayibanda M., Mitchell A.J., Hunt N.H., Rénia L. Control of pathogenic CD8+ T cell migration to the brain by IFN-γ during experimental cerebral malaria. Parasite Immunology 2008, 30:544-553.
8. Berkman N., John M., Roesems G., Jose P.J., Barnes P.J., Chung K.F. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. The Journal of Immunology 1995, 155:4412-4418.
9. Blangero J., Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genetic Epidemiology 1997, 14:959-964.
10. Bliss S.K., Marshall A.J., Zhang Y., Denkers E.Y. Human polymorphonuclear leukocytes produce IL-12, TNF-a, and the chemokines macrophage-inflammatory protein-1a and -1b in response to Toxoplasma gondii antigens. The Journal of Immunology 1999, 162:7369-7375.
11. Burgmann H., Hollenstein U., Wenisch C., Thalhammer F., Looareesuwan S., Graninger W. Serum concentrations of MIP-1 [alpha] and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clinical Immunology and Immunopathology 1995, 76:32-36.
12. Carpenter, D., 2003. Genetics of Susceptibilty to Malaria and Leishmaniasis. PhD Thesis, University of Leeds, Leeds, UK.
13. Carpenter D., Abushama H., Bereczky S., Färnert A., Rooth I., Troye-Blomberg M., Quinnell R.J., Shaw M.-A. Immunogenetic control of antibody responsiveness in a malaria endemic area. Human Immunology 2007, 68:165-169.
14. Carpenter D., Rooth I., Färnert A., Abushama H., Quinnell R.J., Shaw M.-A. Genetics of susceptibility to malaria related phenotypes. Infection, Genetics and Evolution 2009, 9:97-103.
15. Carpenter D., Walker S., Prescott N., Schalkwijk J., Armour J. Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disorders. BMC Genomics 2011, 12:418.
16. Davenport G.C., Ouma C., Hittner J.B., Were T., Ouma Y., Ong'echa J.M., Perkins D.J. Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. American Journal of Hematology 2010, 85:227-233.
17. Garner C., Tatu T., Reittie J.E., Littlewood T., Darley J., Cervino S., Farrall M., Kelly P., Spector T.D., Thein S.L. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000, 95:342-346.
18. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., Nibbs R.J., Freedman B.I., Quinones M.P., Bamshad M.J., Murthy K.K., Rovin B.H., Bradley W., Clark R.A., Anderson S.A., O'Connell R.J., Agan B.K., Ahuja S.S., Bologna R., Sen L., Dolan M.J., Ahuja S.K. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005, 307:1434-1440.
19. Graham G.J., Pragnell I.B. SCI/MIP-1[alpha]: a potent stem cell inhibitor with potential roles in development. Developmental Biology 1992, 151:377-381.
20. Graham G.J., Wright E.G., Hewick R., Wolpe S.D., Wilkie N.M., Donaldson D., Lorimore S., Pragnell I.B. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 1990, 344:442-444.
21. Irving S.G., Zipfel P.F., Balke J., McBride O.W., Morton C.C., Burd P.R., Siebenlist U., Kelly K. Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q. Nucleic Acids Research 1990, 18:3261-3270.
22. Kocherscheidt L., Agossou A., Gantin R.G., Hamm D.M., Banla M., Soboslay P.T. Cytokine and chemokine responses in adults, newborns and children exposed to Entamoeba histolytica/dispar, Onchocerca volvulus and Plasmodium falciparum. Pediatric Allergy and Immunology 2010, 21:e756-e763.
23. Luty A.J.F., Bongartz M., Rezbach P., Faucher J.-F., Hollingdale M.R., Kremsner P.G. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children. European Cytokine Network 2001, 12:647-653.
24. Mackinnon M.J., Mwangi T.W., Snow R.W., Marsh K., Williams T.N. Heritability of malaria in Africa. PLoS Medicine 2005, 2:e340.
25. Maher B. Personal genomes: the case of the missing heritability. Nature 2008, 456:18-20.
26. Menten P., Struyf S., Schutyser E., Wuyts A., De Clercq E., Schols D., Proost P., Van Damme J. The LD78b isoform of MIP-1a is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. The Journal of Clinical Investigation 1999, 104:R1-R5.
27. Moormann Ann M., Sullivan Amy D., Rochford Rosemary A., Chensue Stephen W., Bock Paul J., Nyirenda T., Meshnick Steven R. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. The Journal of Infectious Diseases 1999, 180:1987-1993.
28. Ochiel D.O., Awandare G.A., Keller C.C., Hittner J.B., Kremsner P.G., Weinberg J.B., Perkins D.J. Differential regulation of {beta}-chemokines in children with Plasmodium falciparum malaria. Infection and Immunity 2005, 73:4190-4197.
29. Ong'echa J.M., Davenport G.C., Vulule J.M., Hittner J.B., Perkins D.J. Identification of Inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infection and Immunity 2011, 79:4674-4680.
30. Ordi J., Ismail M.R., Ventura P.J., Kahigwa E., Hirt R., Cardesa A., Alonso P.L., Menendez C. Massive chronic intervillositis of the placenta associated with malaria infection. The American Journal of Surgical Pathology 1998, 22:1006-1011.
31. Perkins D.J., Were T., Davenport G.C., Kempaiah P., Hittner J.B., Ong'echa J.M. Severe malarial anemia: innate immunity and pathogenesis. International Journal of Biological Sciences 2011, 7:1427-1442.
32. Perry G.H., Yang F., Marques-Bonet T., Murphy C., Fitzgerald T., Lee A.S., Hyland C., Stone A.C., Hurles M.E., Tyler-Smith C., Eichler E.E., Carter N.P., Lee C., Redon R. Copy number variation and evolution in humans and chimpanzees. Genome Research 2008, 18:1698-1710.
33. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
34. Ritter U., Moll H., Laskay T.S., Bröcker E.-B., Velazco O., Becker I., Gillitzer R. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. Journal of Infectious Diseases 1996, 173:699-709.
35. Rooth, I., 1992. Malaria Morbidity and Control in a Tanzanian Village. PhD Thesis, Karolinska Institute Stockholm.
36. Sala C., Ciullo M., Lanzara C., Nutile T., Bione S., Massacane R., d'Adamo P., Gasparini P., Toniolo D., Camaschella C. Variation of hemoglobin levels in normal Italian populations from genetic isolates. Haematologica 2008, 93:1372-1375.
37. Standiford T., Kunkel S.L., Liebler J.M., Burdick M.D., Gilbert A.R., Strieter R.M. Gene expression of macrophage inflammatory protein -1alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. American Journal of Respiratory Cell and Molecular Biology 1993, 9:192-198.
38. Teixeira M.J., Fernandes J.D., Teixeira C.R., Andrade B.B., Pompeu M.L., Santana da Silva J., Brodskyn C.I., Barral-Netto M., Barral A. Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infection and Immunity 2005, 73:1191-1195.
39. The Genomes Project Consortium A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
40. Tkachuk Ariana N., Moormann Ann M., Poore Judy A., Rochford Rosemary A., Chensue Stephen W., Mwapasa V., Meshnick Steven R. Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. The Journal of Infectious Diseases 2001, 183:967-972.
41. Townson J.R., Barcellos L.F., Nibbs R.J. Gene copy number regulates the production of the human chemokine CCL3-L1. European Journal of Immunology 2002, 32:3016-3026.
42. Walker S., Janyakhantikul S., Armour J.A.L. Multiplex paralogue ratio tests for accurate measurement of multiallelic CNVs. Genomics 2009, 93:98-103.